These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab]. Tsanyan ME; Torgashina AV; Aleksandrova EN; Soloviev SK; Nasonov EL Ter Arkh; 2013; 85(5):53-9. PubMed ID: 23819340 [TBL] [Abstract][Full Text] [Related]
4. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage. Pottier V; Pierrot M; Subra JF; Mercat A; Kouatchet A; Parrot A; Augusto JF Lupus; 2011 May; 20(6):656-9. PubMed ID: 21335399 [TBL] [Abstract][Full Text] [Related]
5. Pediatric systemic lupus erythematosus in Thammasat University Hospital. Pusongchai T; Jungthirapanich J; Khositseth S J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427 [TBL] [Abstract][Full Text] [Related]
6. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus. Almogren A Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896 [TBL] [Abstract][Full Text] [Related]
7. Common variable immunodeficiency in systemic lupus erythematosus. Fernández-Castro M; Mellor-Pita S; Citores MJ; Muñoz P; Tutor-Ureta P; Silva L; Vargas JA; Yebra-Bango M; Andreu JL Semin Arthritis Rheum; 2007 Feb; 36(4):238-45. PubMed ID: 17276173 [TBL] [Abstract][Full Text] [Related]
8. Rituximab effectiveness in a patient with juvenile systemic lupus erythematosus complicated with acquired Von Willebrand syndrome. Jimenez AR; Vallejo ES; Cruz MZ; Cruz AC; Miramontes JV; Jara BS Lupus; 2013 Dec; 22(14):1514-7. PubMed ID: 23989733 [TBL] [Abstract][Full Text] [Related]
9. B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levels. Lazarus MN; Turner-Stokes T; Chavele KM; Isenberg DA; Ehrenstein MR Rheumatology (Oxford); 2012 Jul; 51(7):1208-15. PubMed ID: 22337941 [TBL] [Abstract][Full Text] [Related]
10. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus]. Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876 [TBL] [Abstract][Full Text] [Related]
11. Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency. Visentini M; Conti V; Cagliuso M; Tinti F; Siciliano G; Trombetta AC; Mitterhofer AP; Fiorilli M; Quinti I Arthritis Rheum; 2009 Sep; 60(9):2767-71. PubMed ID: 19714644 [TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations. Borba EF; Araujo DB; Bonfá E; Shinjo SK Lupus; 2013 Jun; 22(7):744-9. PubMed ID: 23687065 [TBL] [Abstract][Full Text] [Related]
18. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature. Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100 [TBL] [Abstract][Full Text] [Related]
19. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature. Jovancevic B; Lindholm C; Pullerits R Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus. Al Arfaj AS; Chowdhary AR; Khalil N; Ali R Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]